Brief: Vtv Therapeutics Announces Positive Results From Mechanistic Study

vTv Therapeutics

12/10/2021 12:35

Oct 12 (Reuters) - vTv Therapeutics Inc  VTVT.O :
    * VTV THERAPEUTICS ANNOUNCES POSITIVE RESULTS FROM
MECHANISTIC
STUDY INDICATING NO INCREASED RISK OF KETOACIDOSIS WITH TTP399
DURING ACUTE INSULIN WITHDRAWAL IN PATIENTS WITH TYPE 1 DIABETES
    * VTV THERAPEUTICS INC - STUDY ACHIEVED PRIMARY ENDPOINT OF
NON-INFERIORITY ON MEASUREMENT OF KEY BLOOD KETONE LEVELS
    * VTV THERAPEUTICS - PATIENTS TAKING TTP399 REPORTED NO
EVENTS OF
HYPOGLYCEMIA, WHILE FOUR EVENTS OF HYPOGLYCEMIA WERE REPORTED IN
PLACEBO ARM
    * VTV THERAPEUTICS - START-UP ACTIVITIES FOR PHASE 3 PROGRAM
ONGOING WITH TRIALS EXPECTED TO BEGIN IN EARLY 2022

Source text for Eikon:  ID:nGNX5CVZRY 
Further company coverage:  VTVT.O 

 ((Reuters.Briefs@thomsonreuters.com;))